{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["100(2)"],"submitter":["Rodon P"],"funding":["NCI NIH HHS"],"journal":["Haematologica"],"pagination":["e56-9"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4803137"],"repository":["biostudies-literature"],"pubmed_title":["Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial."],"pmcid":["PMC4803137"],"funding_grant_id":["P01 CA155258"],"pubmed_authors":["Royer B","Moreau P","Lenain P","Leleu X","Cony-Makhoul P","Vilque JP","Jardel H","Kolb B","Banos A","Stoppa AM","Chaleteix C","Dejoie T","Roussel M","Garderet L","Dib M","Pegourie B","Mathiot C","Rodon P","Casassus P","Hulin C","Benboubker L","Fontan J","Benramdane R","Tiab M","Fitoussi O","Decaux O","Petillon MO","Traulle C","Anglaret B","Avet-Loiseau H"],"additional_accession":[]},"is_claimable":false,"name":"Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.","description":null,"dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Feb","modification":"2025-05-29T21:25:25.331Z","creation":"2024-11-08T17:37:27.85Z"},"accession":"S-EPMC4803137","cross_references":{"pubmed":["25398832"],"doi":["10.3324/haematol.2014.110890"]}}